SEC Company Response from Valion Bio, (VBIO) — Jan 14, 2026
Valion Bio, Inc.
Date: Jan. 14, 2026 · CIK: 0001787740 · Accession: 0001683168-26-000312
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292467
Letter
Re: Tivic Health Systems, Inc.
Tivic Health Systems, Inc.
47865 Lakeview Blvd.
Fremont, CA 94538
(888) 276-6888
January 14, 2026 VIA EDGAR
United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549
Registration Statement on Form S-3
File No. 333-292467
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Tivic Health Systems, Inc., a Delaware corporation (the "Registrant"), hereby respectfully requests that the United States Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-292467), to become effective on Friday, January 16, 2026, at 5:00 p.m., Eastern Time, or as soon as reasonably practicable thereafter.
The Registrant understands that the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes its counsel, Christopher L. Tinen, Esq. of Snell & Wilmer L.L.P., to orally modify or withdraw this request for acceleration. Please contact Mr. Tinen at (858) 910-4809 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.
Very truly yours,
Tivic Health Systems, Inc.
Show Raw Text
CORRESP 1 filename1.htm Tivic Health Systems, Inc. 47865 Lakeview Blvd. Fremont, CA 94538 (888) 276-6888 January 14, 2026 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: Tivic Health Systems, Inc. Registration Statement on Form S-3 File No. 333-292467 REQUEST FOR ACCELERATION OF EFFECTIVENESS Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Tivic Health Systems, Inc., a Delaware corporation (the "Registrant"), hereby respectfully requests that the United States Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-292467), to become effective on Friday, January 16, 2026, at 5:00 p.m., Eastern Time, or as soon as reasonably practicable thereafter. The Registrant understands that the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement. The Registrant hereby authorizes its counsel, Christopher L. Tinen, Esq. of Snell & Wilmer L.L.P., to orally modify or withdraw this request for acceleration. Please contact Mr. Tinen at (858) 910-4809 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted. Very truly yours, Tivic Health Systems, Inc. By: /s/ Jennifer Ernst Name: Jennifer Ernst Title: Chief Executive Officer cc: Christopher L. Tinen, Snell & Wilmer L.L.P.